CVE-2012-3527

Description

view_help.php in the backend help system in TYPO3 4.5.x before 4.5.19, 4.6.x before 4.6.12 and 4.7.x before 4.7.4 allows remote authenticated backend users to unserialize arbitrary objects and possibly execute arbitrary PHP code via an unspecified parameter, related to a "missing signature (HMAC)."

Category

4.6
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 2.07% Top 20%
Vendor Advisory debian.org Vendor Advisory typo3.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://typo3.org/teams/security/security-bulletins/typo3-core/typo3-core-sa-2012-004/ vendor advisory
http://www.debian.org/security/2012/dsa-2537 third party advisory vendor advisory
http://www.openwall.com/lists/oss-security/2012/08/22/8 mailing list
https://exchange.xforce.ibmcloud.com/vulnerabilities/77791 vdb entry third party advisory
http://osvdb.org/84773 vdb entry broken link
http://secunia.com/advisories/50287 third party advisory not applicable

Frequently Asked Questions

What is the severity of CVE-2012-3527?
CVE-2012-3527 has been scored as a medium severity vulnerability.
How to fix CVE-2012-3527?
To fix CVE-2012-3527, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-3527 being actively exploited in the wild?
It is possible that CVE-2012-3527 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.